{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:40:23Z","timestamp":1794008423559,"version":"4.8.0"},"reference-count":32,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific and Technological Research Council of T\u00fcrkiye (T\u00dcB\u0130TAK), 2209-A University Students Research Projects Support Program","award":["1919B012109351"],"award-info":[{"award-number":["1919B012109351"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Post-COVID-19 fibrotic-like lung changes (PC19-FLC), which may represent persistent post-inflammatory abnormalities or early fibrotic remodeling, have emerged as an important long-term pulmonary sequela following SARS-CoV-2 infection. However, the underlying pathogenic mechanisms remain incompletely understood. This study aimed to investigate the potential association between mammalian target of rapamycin (mTOR) activity and the presence of PC19-FLC. Methods: This single-center, cross-sectional study included 70 patients who met the predefined inclusion criteria. Participants were categorized according to the presence or absence of PC19-FLC on chest computed tomography. Demographic, laboratory, and radiological data were collected. Serum mTOR levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: Serum mTOR levels and modified Medical Research Council (mMRC) dyspnea scores were significantly higher in patients with PC19-FLC compared with those without fibrotic-like changes. Receiver operating characteristic (ROC) curve analysis identified a serum mTOR cut-off value of 6.15 ng\/mL (sensitivity 83%, specificity 94%) for discriminating patients with PC19-FLC in this cohort. Serum mTOR levels were significantly correlated with forced vital capacity (FVC%), mMRC dyspnea score, and peripheral oxygen saturation (SpO2). Conclusions: Increased serum mTOR levels were associated with the presence of fibrotic-like lung changes after COVID-19 and may help distinguish patients with such CT abnormalities in this cohort. Higher mTOR levels were also associated with greater dyspnea severity, lower lung volumes, and reduced peripheral oxygen saturation. These findings suggest a potential role of mTOR signaling in post-COVID-19 pulmonary sequelae and warrant further investigation in larger, multicenter studies.<\/jats:p>","DOI":"10.3390\/diagnostics16060958","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:54:53Z","timestamp":1774281293000},"page":"958","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum Mammalian Target of Rapamycin (mTOR) Levels in Patients with Post-COVID-19 Fibrotic-like Lung Changes: A Cross-Sectional Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Mert","family":"Gebes","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Mugla Sitki Kocman University, Mugla 48000, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-3747","authenticated-orcid":false,"given":"Ozge","family":"Oral Tapan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Pulmonology, Mugla Sitki Kocman University, Mugla 48000, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-9324","authenticated-orcid":false,"given":"Tuba","family":"Edgunlu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Medical Biology, Mugla Sitki Kocman University, Mugla 48000, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Dogan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Radiology, Mugla Sitki Kocman University, Mugla 48000, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"de-las-Pe\u00f1as, C.F., Palacios-Ce\u00f1a, D., G\u00f3mez-Mayordomo, V., Cuadrado, M.L., and Florencio, L.L. (2021). Defining post-covid symptoms (post-acute covid, long covid, persistent post-covid): An integrative classification. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18052621"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.25709","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s13054-020-03197-7","article-title":"A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection","volume":"24","author":"Cruces","year":"2020","journal-title":"Crit. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s41030-023-00226-y","article-title":"Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review","volume":"9","year":"2023","journal-title":"Pulm. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","article-title":"Post covid 19 pulmonary fibrosis. Is it real threat?","volume":"68","author":"Rai","year":"2021","journal-title":"Indian J. Tuberc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/atm.atm_7_23","article-title":"Post-COVID-19 pulmonary fibrosis: An ongoing concern","volume":"18","author":"Alrajhi","year":"2023","journal-title":"Ann. Thorac. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lawrence, J., and Nho, R. (2018). The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030778"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.jinf.2020.04.008","article-title":"Risk factors associated with disease severity and length of hospital stay in COVID-19 patients","volume":"81","author":"Liu","year":"2020","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.41.6.2633-2640.2003","article-title":"Herpes virus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis","volume":"41","author":"Tang","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijrobp.2016.07.026","article-title":"Mammalian Target of Rapamycin Inhibition With Rapamycin Mitigates Radiation-Induced Pulmonary Fibrosis in a Murine Model","volume":"96","author":"Chung","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI11963","article-title":"TGF-beta is a critical mediator of acute lung injury","volume":"107","author":"Pittet","year":"2001","journal-title":"J. Clin. Invest."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0360-3016(00)00482-X","article-title":"Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation","volume":"47","author":"Uthe","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e148476","DOI":"10.1172\/jci.insight.148476","article-title":"Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection","volume":"6","author":"Chun","year":"2021","journal-title":"JCI Insight"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccm.2004.05.005","article-title":"Resting and exercise physiology in interstitial lung diseases","volume":"25","author":"Lama","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/thoraxjnl-2015-207011","article-title":"Effect of continued treatmentwith pirfenidone following clinically meaningful declines in forcedvital capacity: Analysis of data from three phase 3 trials in patientswith idiopathic pulmonary fibrosis","volume":"71","author":"Nathan","year":"2016","journal-title":"Thorax"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.resinv.2019.12.010","article-title":"Pulse oximetry saturation can predict prognosis of idiopathic pulmonary fibrosis","volume":"58","author":"Takei","year":"2020","journal-title":"Respir. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.arbres.2020.06.012","article-title":"Comorbidities and Mortality in PatientsWith COVID-19 Aged 60 Years and Older in a University Hospital in Spain","volume":"56","author":"Posso","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6175964","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulm. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","article-title":"Epigenetic memory of coronavirus infection in innate immune cells and their progenitors","volume":"186","author":"Cheong","year":"2023","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jiac.2022.08.007","article-title":"Post COVID-19 condition of the Omicron variant of SARS-CoV-2","volume":"28","author":"Morioka","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhou, F., Tao, M., Shang, L., Liu, Y., Pan, G., Jin, Y., Wang, L., Hu, S., Li, J., and Zhang, M. (2021). Assessment of Sequelae of COVID-19 nearly 1 year after diagnosis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.717194"},{"key":"ref_29","first-page":"100973","article-title":"Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19","volume":"82","author":"Hinnen","year":"2022","journal-title":"Respir. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3348\/kjr.2020.0215","article-title":"Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia","volume":"21","author":"Yu","year":"2020","journal-title":"Korean J. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"K\u0131z\u0131l\u0131rmak, D., Sar\u0131, S., Can, F., and Havlucu, Y. (2023). Radiological findings based comparison of functional status in patients who have post-covid lung injury or idiopathic pulmonary fibrosis. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02527-z"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Aguilar, D., Bosacoma, A., Blanco, I., Tura-Ceide, O., Serrano-Mollar, A., Barber\u00e0, J.A., and Peinado, V.I. (2022). Differences and similarities between the lung transcriptomic profiles of COVID-19, COPD, and IPF Patients: A Meta-analysis study of Pathophysiological Signaling Pathways. Life, 12.","DOI":"10.3390\/life12060887"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/6\/958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:01:05Z","timestamp":1774281665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/6\/958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["diagnostics16060958"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16060958","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}